We are live on ! Find out more
ALXO icon

ALX Oncology

84 hedge funds and large institutions have $21.7M invested in ALX Oncology in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 86 → 84 (-2)

12.67% less ownership

Funds ownership: 77.8% → 65.13% (-13%)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

58% less call options, than puts

Call options by funds: $24K | Put options by funds: $57K

79% less capital inflows, than outflows

Capital inflows: $2.04M | Capital outflows: $9.7M

Holders
84
Holders Change
-2
Holders Change %
-2.33%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
7
Increased
26
Reduced
30
Closed
9
Calls
$24​K
Puts
$57​K
Net Calls
-⁠$33​K
Net Calls Change
-⁠$269​K

ALXO Hedge Fund Activity: Q1 2025 in Review

84 of the 7,490 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q1 2025, worth a combined $21.7M — down 68% from $68.5M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ALXO and 7 opened new positions — a net loss of 2 holders — while 30 trimmed existing stakes and 26 added.

The largest buyer was Bank of America, adding an estimated $500K. The largest seller was Morgan Stanley, cutting an estimated $2.57M.

  • 84 institutional investors held ALX Oncology (ALXO) as of Q1 2025, down from 86 in Q4 2024.
  • Funds reported $21.7M of ALX Oncology stock for Q1 2025, down 68% quarter-over-quarter.
  • 7 funds opened new ALX Oncology positions in Q1 2025 and 9 closed out, a net change of -2 holders.
  • The largest ALX Oncology buyer in Q1 2025 was Bank of America, an estimated $500K added.
  • The largest ALX Oncology seller in Q1 2025 was Morgan Stanley, an estimated $2.57M sold.

Based on aggregated 13F filings for Q1 2025.